article thumbnail

An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025

MedCity News

Isomorphic Labs financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector. The post An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025 appeared first on MedCity News. Biotech financing activity has been slowing down, analysts say.

Biopharma 272
article thumbnail

Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More

MedCity News

The post Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More appeared first on MedCity News. Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year.

Biopharma 306
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

10 Key MedTech Themes for 2025

MedCity News

The MedTech industry has demonstrated remarkable resilience in navigating uncertainty, and 2025 promises to be a pivotal year as the election supercycle concludes and AI regulatory frameworks become clearer. The post 10 Key MedTech Themes for 2025 appeared first on MedCity News.

Medical 231
article thumbnail

Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World

MedCity News

Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the World appeared first on MedCity News. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced cases of certain blood cancers. Takeda holds an exclusive option to develop and commercialize one of those drugs in most of the world.

Pharma 231
article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line.

article thumbnail

Who is Speaking at INVEST 2025?

MedCity News

The post Who is Speaking at INVEST 2025? The healthcare investor conference, scheduled for May 20 and 21 at the Willis Tower in Chicago, combines panel discussions, networking opportunities, and a startup pitch contest. Register today! appeared first on MedCity News.

article thumbnail

How Are Hospitals Faring Financially in 2025?

MedCity News

Hospitals started 2025 with a stable financial performance driven by strong patient volumes, but rising costs for drugs, supplies, and services continue to put major pressure on margins. The post How Are Hospitals Faring Financially in 2025? appeared first on MedCity News.

Patients 300
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

📆 March 5, 2025 at 9:30am PT, 12:30pm ET, 5:30pm GMT . 🌟 Future Readiness: Gain actionable steps to prepare your marketing and sales teams for the AI-driven future. Be part of the conversation! Register now to explore the future of AI in sales and marketing!

article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact.

article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

📆 April 3, 2025 at 9:30am PT, 12:30pm ET, 4:30pm GMT . ⚡ The latest technology trends shaping the future of sales and customer engagement for long-term success. Register today to learn how to implement AI and automation in a way that enhances, not replaces, the human side of sales!